News ArchivesRead News
Exposure to industrial solvent 'can increase risk of Parkinson's disease six times'
Friday March 22, 2013
Chemical is banned in food and pharmaceutical industries but is still used as a degreasing agent 30% of U.S. drinking water supplies believed to be contaminated Read more: http://www.dailymail.co.uk/health/article-2061257/Exposure-industrial-solvent
dailymail.co.uk - Chemical is banned in food and pharmaceutical industries but is still used as a degreasing agent
30% of U.S. drinking water supplies believed to be contaminated
A team of scientists from the U.S, Canada, Germany and Argentina found that individuals who had been exposed in the workplace to trichloroethylene (TCE) were six-times more likely to develop Parkinson's.
Due to concerns about its toxicity, the use of TCE in the food and pharmaceutical industries has been banned across much of the world since the 1970s.
However, the chemical is still used as a degreasing agent.
Dr Samuel Goldman of The Parkinson's Institute in Sunnyvale, California, who co-led the study published in the journal Annals of Neurology, told the BBC: 'Our study confirms that common environmental contaminants may increase the risk of developing Parkinson's, which has considerable public health implications.
'Our findings, as well as prior case reports, suggest a lag time of up to 40 years between TCE exposure and onset of Parkinson's, providing a critical window of opportunity to potentially slow the disease before clinical symptoms appear.'
Parkinson's disease is caused by a loss of nerve cells in part of the brain.
It can results in limb tremors, slowed movement and speech impairment.
Researchers wanted to look at the impact on people of exposure to six different solvents, including TCE.
The new findings was based on analysis of 99 pairs of twins from America, one twin with Parkinson's and the other without.
Scientists looked at the work history of the twins as well as hobbies and interests, so they could calculate their exposure to solvents.
n the past TCE has been used in glue, carpet-cleaners, paints and dry-cleaning solutions.
It is still used as a degreasing agent for metal parts.
It is also estimated that 30 per cent of U.S. drinking water supplies are contaminated with the chemical.
Dr Michelle Gardner, research development manager at Parkinson's UK, told the BBC that more research needed to be carried out to look at the link between solvents like TCE and Parkinson's.
She added: 'This is the first study to show that the solvent TCE may be associated with an increased risk of developing Parkinson's.
'It is important to highlight that many of the previous uses of this solvent have been discontinued for safety reasons over 30 years ago, and that safety and protection in work places where strong chemicals such as this solvent are used has greatly improved in recent years.'
Two other solvents - perchloroethylene (PERC) and carbon tetrachloride (CCl4) - were also found to pose a significant risk of developing the disease if people were exposed to them.
There was no link found with the three other solvents examined in the study - toluene, xylene and n-hexane.
PERC is used as a dry-cleaning agent and degreasing agent.
CCl4's major use in the past was in the manufacture of chlorofluorocarbons for use as refrigerants.
Recent NewsOct 18 - Fighting Parkinson's disease through dance
Oct 18 - Brain disconnections may contribute to Parkinson's hallucinations
Oct 17 - Scientists Identify Structure of PINK1, Key Parkinson’s-protective Protein
Oct 17 - Diabetes drug cuts Parkinson's risk by 28 percent, study finds
Oct 10 - Advances in Brain Pacemaker Reduces Tremors, Helps Parkinson's Sufferers Live a More Normal Life
Oct 10 - Medical History Could Help Predict Parkinson's Disease Risk Long Before Diagnosis
Oct 3 - Changes in Olfactory Bulb Explain Loss of Smell in Early Stages of Parkinson’s Disease, Study Finds
Oct 3 - Sleep Disturbances May Worsen Motor Symptoms in Parkinson’s Disease, Study Suggests
Sep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show